Substance or medication-induced anxiety disorder: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
Line 3: Line 3:
{{CMG}} {{AE}} {{KS}}
{{CMG}} {{AE}} {{KS}}
==Overview==
==Overview==
 
According to the DSM-V, substance/medication-induced anxiety disorder is characterized by panic attacks or anxiety that develops during or after substance intoxication or withdrawal or after exposure to a medication.
==Differential Diagnosis==
==Differential Diagnosis==
*[[Anxiety disorder]] (i.e., not induced by a substance/medication)
*[[Anxiety disorder]] (i.e., not induced by a substance/medication)
*[[Anxiety disorder]] due to another medical condition
*[[Anxiety disorder]] due to another medical condition
*[[Delirium]]
*[[Delirium]]
*Substance intoxication and substance withdrawal<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>
*Substance intoxication
*Substance withdrawal<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==

Latest revision as of 16:48, 13 November 2014

Template:Anxiety disorder Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

According to the DSM-V, substance/medication-induced anxiety disorder is characterized by panic attacks or anxiety that develops during or after substance intoxication or withdrawal or after exposure to a medication.

Differential Diagnosis

Epidemiology and Demographics

Prevalence

The prevalence of substance or medication-induced anxiety disorder is not clear in the overall population.[1]

Diagnostic Criteria

DSM-V Diagnostic Criteria for Substance/Medication-Induced Anxiety Disorder [1]

“

AND

  • B. There is evidence from the history, physical examination, or laboratory findings of both (1)and (2):
  • 1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
  • 2. The involved substance/medication is capable of producing the symptoms in Criterion A.

AND

  • C. The disturbance is not better explained by an anxiety disorder that is not substance/medication-induced. Such evidence of an independent anxiety disorder could include

the following:

  • The symptoms precede the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication: or there is other evidence suggesting the existence of an independent non-substance/medication-induced anxiety disorder

(e.g., a history of recurrent non-substance/medication-related episodes).

AND

  • D. The disturbance does not occur exclusively during the course of a delirium.

AND

  • E. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and they are sufficiently severe to warrant clinical attention.

”

References

  1. ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Substance_or_medication-induced_anxiety_disorder&oldid=1041073"